Susan Pederson

1.7k total citations · 2 hit papers
20 papers, 1.0k citations indexed

About

Susan Pederson is a scholar working on Psychiatry and Mental health, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Susan Pederson has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Physiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Susan Pederson's work include Migraine and Headache Studies (8 papers), Sympathectomy and Hyperhidrosis Treatments (4 papers) and Hemostasis and retained surgical items (3 papers). Susan Pederson is often cited by papers focused on Migraine and Headache Studies (8 papers), Sympathectomy and Hyperhidrosis Treatments (4 papers) and Hemostasis and retained surgical items (3 papers). Susan Pederson collaborates with scholars based in United States, Australia and Georgia. Susan Pederson's co-authors include Barbara Schaeffler, Joe Hirman, Brent Allan, Roger Cady, Jeff Smith, David M. Biondi, Peter J. Goadsby, Richard B. Lipton, Messoud Ashina and Joel R. Saper and has published in prestigious journals such as Blood, Neurology and Frontiers in Immunology.

In The Last Decade

Susan Pederson

19 papers receiving 1.0k citations

Hit Papers

Efficacy and safety of eptinezumab in patients with chron... 2020 2026 2022 2024 2020 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of eptinezumab in patients with chronic migraine
    2020 273 citations Richard B. Lipton, Peter J. Goadsby et al. Neurology profile →
  2. Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
    2020 264 citations Messoud Ashina, Joel R. Saper et al. Cephalalgia profile →

Peers

Susan Pederson
Patricia Mulero Spain
Mariangela Farinotti Italy
Uğur Uygunoğlu Türkiye
Frederick J. Derosier United States
M. Chris Runken United States
M. Brown United States
Alby Elias United States
Barbara Frigeni Italy
Ellis Niemantsverdriet Netherlands
Patricia Mulero Spain
Susan Pederson
Citations per year, relative to Susan Pederson Susan Pederson (= 1×) peers Patricia Mulero

Countries citing papers authored by Susan Pederson

Since Specialization
Citations

This map shows the geographic impact of Susan Pederson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Pederson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Pederson more than expected).

Fields of papers citing papers by Susan Pederson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Pederson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Pederson. The network helps show where Susan Pederson may publish in the future.

Co-authorship network of co-authors of Susan Pederson

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Pederson. A scholar is included among the top collaborators of Susan Pederson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Pederson. Susan Pederson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pederson, Susan, David M. Biondi, Brent Allan, et al.. (2021). Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine. Frontiers in Immunology. 12. 765822–765822. 2 indexed citations
2.
Kudrow, David, Roger Cady, Brent Allan, et al.. (2021). Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial. BMC Neurology. 21(1). 126–126. 63 indexed citations
3.
Baker, Brian, Barbara Schaeffler, Joe Hirman, et al.. (2021). Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Endocrinology Diabetes & Metabolism. 4(2). e00217–e00217. 9 indexed citations
4.
Silberstein, Stephen D., Merle L. Diamond, Nada Hindiyeh, et al.. (2020). Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study. The Journal of Headache and Pain. 21(1). 120–120. 72 indexed citations
5.
Lipton, Richard B., Peter J. Goadsby, Jeff Smith, et al.. (2020). Efficacy and safety of eptinezumab in patients with chronic migraine. Neurology. 94(13). e1365–e1377. 273 indexed citations breakdown →
6.
Smith, Timothy R., Marina Janelidze, Roger Cady, et al.. (2020). Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study. Clinical Therapeutics. 42(12). 2254–2265.e3. 41 indexed citations
7.
8.
Baker, Brian, Barbara Schaeffler, Martin Béliveau, et al.. (2020). Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine. Pharmacology Research & Perspectives. 8(2). e00567–e00567. 48 indexed citations
9.
Ashina, Messoud, Joel R. Saper, Roger Cady, et al.. (2020). Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1). Cephalalgia. 40(3). 241–254. 264 indexed citations breakdown →
10.
Ma, Mark, Kelly Colletti, Tong‐Yuan Yang, et al.. (2019). Bioanalytical Challenges and Unique Considerations to Support Pharmacokinetic Characterization of Bispecific Biotherapeutics. Bioanalysis. 11(5). 427–435. 5 indexed citations
11.
12.
Wong, Teresa, et al.. (2014). Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs. mAbs. 6(5). 1178–1189. 14 indexed citations
13.
Byrnes-Blake, Kelly, Susan Pederson, Kevin Klucher, et al.. (2012). Pharmacokinetics and Pharmacodynamics of Pegylated Interferon Lambda-1 in Cynomolgus Monkeys. Journal of Interferon & Cytokine Research. 32(5). 198–206. 7 indexed citations
14.
Kim, Hye Jeong, et al.. (2012). Improving user satisfaction via a case‐enhanced e‐learning environment. Education + Training. 54(2/3). 204–218. 24 indexed citations
15.
Pederson, Susan, et al.. (2011). The North Dakota oil boom: changing the landscape of a community's health.. PubMed. 80(1). 10–10. 1 indexed citations
16.
Dillon, Stacey R., Brandon Harder, Kenneth B. Lewis, et al.. (2010). B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin. Arthritis Research & Therapy. 12(2). R48–R48. 81 indexed citations
17.
Ponce, Rafael, Linda A. Zuckerman, Jennifer Visich, et al.. (2006). Preclinical safety of recombinant human thrombin. Regulatory Toxicology and Pharmacology. 47(1). 48–58. 23 indexed citations
18.
Visich, Jennifer, Michael D. Butine, Guy Young, et al.. (2006). Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood. 108(1). 57–62. 82 indexed citations
19.
Ponce, Rafael, Jennifer Visich, Kenneth B. Lewis, et al.. (2005). Preclinical Safety and Pharmacokinetics of Recombinant Human Factor XIII. Toxicologic Pathology. 33(4). 495–506. 13 indexed citations
20.
Soucy, Robert & Susan Pederson. (1995). Family, Dependence, and the Origins of the Welfare State: Britain and France, 1914-1945. The Journal of Interdisciplinary History. 26(2). 297–297. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Mulero Breakdown of academic impact, for papers by Mariangela Farinotti Breakdown of academic impact, for papers by Uğur Uygunoğlu Breakdown of academic impact, for papers by Frederick J. Derosier Breakdown of academic impact, for papers by M. Chris Runken Breakdown of academic impact, for papers by M. Brown Breakdown of academic impact, for papers by Alby Elias Breakdown of academic impact, for papers by Barbara Frigeni Breakdown of academic impact, for papers by Ellis Niemantsverdriet
Rankless by CCL
2026